Institutional investors hold a majority ownership of TEVA through the 59.40% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended March 2016, these large investors purchased a net $10.2 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ETHENEA INDEPENDENT INVESTORS SA Bought 400.0 Thousand shares of Teva Pharmaceutical